JABLX
Price
$51.07
Change
-$0.52 (-1.01%)
Updated
Jun 13 closing price
Net Assets
8.97B
RLBBX
Price
$35.35
Change
-$0.31 (-0.87%)
Updated
Jun 13 closing price
Net Assets
244.39B
Interact to see
Advertisement

JABLX vs RLBBX

Header iconJABLX vs RLBBX Comparison
Open Charts JABLX vs RLBBXBanner chart's image
Janus Henderson VIT Balanced Instl
Price$51.07
Change-$0.52 (-1.01%)
VolumeN/A
Net Assets8.97B
American Funds American Balanced R2
Price$35.35
Change-$0.31 (-0.87%)
VolumeN/A
Net Assets244.39B
JABLX vs RLBBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JABLX vs. RLBBX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JABLX is a Buy and RLBBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 244B vs. JABLX (8.97B). JABLX pays higher dividends than RLBBX: JABLX (1.96) vs RLBBX (1.23). JABLX was incepted earlier than RLBBX: JABLX (32 years) vs RLBBX (23 years). RLBBX (1.32) is less costly to investors than JABLX (0.62). JABLX is a more actively managed with annual turnover of: 83.00 vs. RLBBX (44.00). JABLX has a lower initial minimum investment than RLBBX: JABLX (0) vs RLBBX (250). JABLX annual gain was more profitable for investors over the last year : 5.46 vs. RLBBX (4.47). JABLX return over 5 years is better than : 47.24 vs. RLBBX (34.04).
JABLXRLBBXJABLX / RLBBX
Total Expense Ratio0.621.3247%
Annual Report Gross Expense Ratio0.621.3247%
Fund Existence32 years23 years-
Gain YTD0.7634.08219%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets8.97B244B4%
Annual Yield % from dividends1.961.23159%
Returns for 1 year5.464.47122%
Returns for 3 years33.7730.06112%
Returns for 5 years47.2434.04139%
Returns for 10 years92.2951.22180%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PPBT2.45-0.01
-0.41%
Purple Biotech Ltd
AOS63.81-0.44
-0.68%
AO Smith Corp
VINP9.40-0.12
-1.26%
Vinci Partners Investments Ltd
LEG9.24-0.33
-3.45%
Leggett & Platt
TARA3.14-0.12
-3.68%
Protara Therapeutics